A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
PHASE1CompletedINTERVENTIONAL
Enrollment
6
Participants
Timeline
Start Date
January 31, 1988
Primary Completion Date
January 31, 1990
Conditions
HIV InfectionsCognition Disorders
Interventions
DRUG
Peptide T
Trial Locations (1)
90033
Los Angeles County - USC Med Ctr, Los Angeles
All Listed Sponsors
lead
National Institute of Mental Health (NIMH)
NIH
NCT00000393 - A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). | Biotech Hunter | Biotech Hunter